Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.

Completed · Phase 2 · Has a placebo group

Conditions studied: Asthma

In brief

This study is a randomized, double-blind, placebo-controlled, three-period cross-over study in approximately 54 subjects with asthma.

Key facts

Study ID

NCT03257995

Run by

Novartis Pharmaceuticals

People needed

54

Starts

2017-09-05

Expected to finish

2018-01-18

Last updated by the study team

2021-01-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Novartis Investigative Site — North Dartmouth, Massachusetts, United States
• Novartis Investigative Site — St Louis, Missouri, United States
• Novartis Investigative Site — Skillman, New Jersey, United States
• Novartis Investigative Site — Raleigh, North Carolina, United States
• Novartis Investigative Site — Medford, Oregon, United States
• Novartis Investigative Site — El Paso, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.